Diamedica Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.28

+0.39 (+6.62%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -33.8% upside

Low Target $2.49

Average Target $4.16

High Target $4.48

Current Price $6.28

Current
$6.28

Target
$4.16

$2.49 $4.16 avg $4.48

Scenario Analysis

Bear Case

$2.49

-60.4%

Low target

Base Case

$4.16

-33.8%

Avg target

Bull Case

$4.48

+-28.7%

High target

Risk/Reward

0.5x

Unfavorable

Price in Context

52-Week High

$10.42

-39.7% from high

52-Week Low

$3.48

+80.7% from low

Target vs 52W High

$4.16

-60.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.0%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+190.0%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-6.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-64.5%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.7%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-39.1%